Intragastric Balloon: a Retrospective Evaluation of 5874 Patients on Tolerance, Complications, and Efficacy in Different Degrees of Overweight

Fittipaldi-Fernandez, Ricardo J.; Zotarelli-Filho, Idiberto José; Diestel, Cristina F.; Klein, Márcia Regina Simas Torres; Galvao, Manoela; Lima, João Henrique Felício de; Bastos, Fernando Santos Silva; Santos, Newton Teixeira dos

doi:10.1007/s11695-020-04985-4

Cited by 24 publications

(31 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other important complications uncovered from this database include balloon hyperinflation (2.3%) and acute pancreatitis [23]. In terms of tolerability, early IGB removal rates were 6.1% in a large retrospective study of 5874 patients [26]. These were attributed mostly to persistent accommodative symptoms like nausea, vomiting, and abdominal pain.…”

Section: Intragastric Balloonsmentioning

confidence: 99%

Endobariatrics: well past infancy and maturing rapidly

Shrestha

Shah

2022

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

Purpose of reviewThis review summarizes the key developments with regard to FDA-approved endoscopic bariatric metabolic therapies (EBMTs) in the last 2 years.Recent findingsThe prevalence of obesity has increased during the coronavirus disease 2019 (COVID-19) pandemic, and obesity worsens COVID-19 related outcomes. Several studies have confirmed the safety and short-term efficacy of intragastric balloons (IGBs). In the short-term IGBs may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health. Unfortunately weight loss from these temporarily placed devices is not sustained long-term. Endoscopic sleeve gastroplasty (ESG) may be more effective and durable than IGBs, and result in fewer adverse events compared to bariatric surgery. The recently completed MERIT trial may catapult ESG as a first-line EBMT. Aspiration therapy meets safety and effectiveness thresholds for incorporation into routine practice, but overall acceptance has been lower than other FDA-approved EBMTs.SummaryThe field of endobariatrics is rapidly maturing. Significant knowledge gaps remain with regards to combining EBMTs with pharmacologic therapy to improve durability of weight loss. The rapid expansion in the literature supporting safety and long-term efficacy ESG may prompt revision of existing guidelines.

show abstract

Section: Intragastric Balloonsmentioning

confidence: 99%

Endobariatrics: well past infancy and maturing rapidly

Shrestha

Shah

2022

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

show abstract

“…The most recently published study was that from 5 private clinics in Brazil (2000-2017) by Fittipaldi-Fernandez et al [ 68 ], which included 5874 patients in whom a liquid-filled balloon not named, but having characteristics intimating the Orbera was placed (600-700 mL saline). After 6 to 7 mo, patients were found to have a weight loss of 19.13 ± 8.86 kg, and a %TWL of 18.42 ± 7.25%, treatment success rate, i.e.…”

Section: Effectiveness For Body Weight Lossmentioning

confidence: 99%

Six intragastric balloons: Which to choose?

Stavrou¹,

Shrewsbury²,

Kotzampassi³

2021

WJGE

View full text Add to dashboard Cite

Endoscopically placed intragastric balloons (IGBs) have played a significant role in obesity treatment over the last 30 years, successfully bridging the gap between lifestyle modification/pharmacotherapy and bariatric surgery. Since they provide a continuous sensation of satiety that helps the ingestion of smaller portions of food, facilitating maintenance of a low-calorie diet, they have generally been considered an effective and reversible, less invasive, non-surgical procedure for weight loss. However, some studies indicate that balloons have limited sustainable effectiveness for the vast majority attempting such therapy, resulting in a return to the previous weight after balloon removal. In this review we try to summarize the pros and cons of various balloon types, to guide decision making for both the physician and the obese individual looking for effective treatment. We analyzed the six most commonly used IGBs, namely the liquid-filled balloons Orbera, Spatz3, ReShape Duo and Elipse, and the gas-filled Heliosphere and Obalon - also including comments on the adjustable Spatz3, and the swallowable Obalon and Elipse - to optimize the choice for maximum efficacy and safety.

show abstract

“…Most IGBs are oval or round and have a volume of 400-700 mL. IGBs may be filled with a fluid, a gas or a combination of both [25][26][27][28]. The Reshape Duo™ (ReShape Lifesciences™, San Clemente, CA, USA) uses two balloons in order to decrease the risk of balloon migration [29].…”

Section: Intragastric Balloons (Igb)mentioning

confidence: 99%

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

et al. 2021

View full text Add to dashboard Cite

Obesity is a significant problem worldwide. Several serious diseases that decrease patient quality of life and increase mortality (high blood pressure, dyslipidaemia, type 2 diabetes etc.) are associated with obesity. Obesity treatment is a multidisciplinary and complex process that requires maximum patient compliance. Change of lifestyle is fundamental in the treatment of obesity. While pharmacotherapeutic options are available, their efficacy is limited. Surgical treatment though highly effective, carries the risk of complications and is thus indicated mostly in advanced stages of obesity. Endoscopic treatments of obesity are less invasive than surgical options, and are associated with fewer complications and nutritional deficits. Currently, there is a large spectrum of endoscopic methods based on the principles of gastric volume reduction, size restriction and gastric or small bowel bypass being explored with only few available in routine practice. The aim of this publication is to present an up-to-date summary of available endoscopic methods for the treatment of obesity focusing on their efficacy, safety and nutritional aspects.

show abstract

Intragastric Balloon: a Retrospective Evaluation of 5874 Patients on Tolerance, Complications, and Efficacy in Different Degrees of Overweight

Cited by 24 publications

References 23 publications

Endobariatrics: well past infancy and maturing rapidly

Endobariatrics: well past infancy and maturing rapidly

Six intragastric balloons: Which to choose?

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

Contact Info

Product

Resources

About